Open AccessP1576: A PHASE 3 RANDOMIZED, DOUBLE‐BLIND, COMPARATOR‐CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU‐STEM)
Author(s) -
Wilck M.,
Cornely O.,
Ljungman P.,
Cordonnier C.,
Diego Velez J.,
Dagan R.,
Richmond P.,
Chen Q.,
Daus C.,
Geddie K.,
Sterling T.,
Shekar T.,
Musey L.,
Buchwald U.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849160.61177.a4
Subject(s) - medicine , immunogenicity , pneumococcal conjugate vaccine , vaccination , tolerability , adverse effect , hematopoietic stem cell transplantation , serotype , pneumococcal vaccine , immunology , clinical trial , transplantation , pediatrics , streptococcus pneumoniae , antibody , biology , genetics , bacteria